| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 05/18/2006 | WO2005091969B1 Pre-symptomatic markers for diseases associated with transmissible spongiform encephalopathies |
| 05/18/2006 | WO2005067633A3 Method and apparatus for presentation of noninvasive glucose concentration information |
| 05/18/2006 | WO2005056601A3 Human anti-pseudomonas-aeruginosa antibodies derived from transgenic xenomouse? |
| 05/18/2006 | WO2005056055A3 METHODS OF PROTECTING AGAINST RADIATION USING INDUCERS OF NF-κB |
| 05/18/2006 | WO2005048012A3 Methods for haplotype assignment |
| 05/18/2006 | WO2005033245A8 Fluorescent compound |
| 05/18/2006 | WO2005012544A3 Methods for the identification of inhibitors of mannosyltransferase and mannosyltransferase complex subunit as antibiotics |
| 05/18/2006 | WO2005012497A3 Translocation tagging |
| 05/18/2006 | WO2005009339A3 Inflammatory bowel diseases |
| 05/18/2006 | WO2005001112A3 RIBOSOMAL RNA METHYLTRANSFERASES R1mA: TARGET VALIDATION AND PROCESSES FOR DEVELOPING AN INHIBITOR ASSAY AND IDENTIFICATION CANDIDATE INHIBITORS |
| 05/18/2006 | WO2004109292A3 Method and means for the determination of defined states or modifications in the mucus of the uterus or in the epithelium of other organs |
| 05/18/2006 | WO2004083818A3 Methods of identifying drug targets and modulators of neurons and compositions comprising the same |
| 05/18/2006 | WO2004074445A3 Model for studying the role of genes in tumor resistance to chemotherapy |
| 05/18/2006 | WO2004065957A8 Device for measuring the quality and/or degradation of a fluid, particularly a food oil |
| 05/18/2006 | WO2004014306A3 Compositions and methods for the treatment of diseases exhibiting protein misassembly and aggregation |
| 05/18/2006 | WO2004006837A3 Mesothelin vaccines and model systems |
| 05/18/2006 | WO2003100082A3 Methods of determining precise herg interactions and altering compounds based on said interactions |
| 05/18/2006 | WO2003075854A8 Cancer-linked gene as target for chemotherapy |
| 05/18/2006 | US20060107351 Cell visual characteristic-modifying sequences |
| 05/18/2006 | US20060107340 Calpain large subunit (n-CL4) cysteine protease gene disruptions, and compositions and methods related thereto |
| 05/18/2006 | US20060107336 Nonbacterial prostatitis model animal |
| 05/18/2006 | US20060106621 Cipher information-containing material, its identifying method, and its identifying system |
| 05/18/2006 | US20060106544 Method and system for predicting functions of compound |
| 05/18/2006 | US20060106202 Peripheral-type benzodiazepine receptor associated proteins, cloning, expression and methods of use |
| 05/18/2006 | US20060106201 Novel hemopoietin receptor protein, NR12 |
| 05/18/2006 | US20060106199 Streptavidin-binding peptide |
| 05/18/2006 | US20060106078 Prostamide receptor antagonists |
| 05/18/2006 | US20060106072 Compounds having selective activity for Retinoid X Receptors, and means for modulation of processes mediated by Retinoid X Receptors |
| 05/18/2006 | US20060105472 Reduction of non-specific binding in assays |
| 05/18/2006 | US20060105471 Coated metal surface on solid support useful in analyte detection by displacement |
| 05/18/2006 | US20060105470 For detecting early conception factor in a body fluid from an animal comprising the antibodies which specifically bind early conception factor |
| 05/18/2006 | US20060105469 Assay devices |
| 05/18/2006 | US20060105466 Sensor for determining concentration of ozone |
| 05/18/2006 | US20060105464 Quantitative determination of analyte |
| 05/18/2006 | US20060105463 Distinction method for the catch capacity of proteins |
| 05/18/2006 | US20060105455 Covalently attached collagen VI for cell attachment and proliferation |
| 05/18/2006 | US20060105451 Genetically engineered P30 antigen improved antigen cocktail, and uses thereof |
| 05/18/2006 | US20060105445 Medium and method for enriching, purifying or depleting atp binding proteins from a pool of proteins |
| 05/18/2006 | US20060105422 Homocysteine assay |
| 05/18/2006 | US20060105418 Immobilization support, process for producing the same, electrode, process for producing the same, electrode reaction utilizing apparatus and process for producing the same |
| 05/18/2006 | US20060105416 For the determination of an analyte or analytes such as proteins, peptides, nucleic acids, carbohydrates, lipids, steroids and small molecules by mass analysis |
| 05/18/2006 | US20060105413 For modulating NF- kappa B signaling |
| 05/18/2006 | US20060105411 Method of detecting early pregnancy at high accuracy by measuring hCG and hyperglycosylated hCG concentrations equally |
| 05/18/2006 | US20060105410 Sulfonate compound and fluorescent probe using the same |
| 05/18/2006 | US20060105409 Ubiquitin ligase assay |
| 05/18/2006 | US20060105408 Myeloperoxidase, a risk indicator for cardiovascular disease |
| 05/18/2006 | US20060105407 Protein chip for analyzing interaction between protein and substrate peptide thereof |
| 05/18/2006 | US20060105406 Cytoplasmic antigens for detection of Candida |
| 05/18/2006 | US20060105404 For diagnosis of disease and identification of HDC inhibitor agents;cancer, asthma and mastocytoma, immunological disorders, and gastrointestinal disorders |
| 05/18/2006 | US20060105403 Braca1/acc alpha molecular complexes, diagnostic and therapeutic applications |
| 05/18/2006 | US20060105402 Blood type method system and device |
| 05/18/2006 | US20060105401 Diagnostic method for screening complement regulatory protein levels to predict spontaneous abortion |
| 05/18/2006 | US20060105400 Elisa kits for detecting collagenase 3 as a proenzyme and in an activated form in body fluids and cell culture supernatants |
| 05/18/2006 | US20060105399 Conductive polymer matrix and device for use in the efficient isolation of preferential stem cells; permits the monitoring of cell binding to the solid matrix during the selection process, it is possible to obtain feedback information on the number of selected cells at any time |
| 05/18/2006 | US20060105398 Methods of identifying compounds that modulate igg mediated mast cell activation |
| 05/18/2006 | US20060105397 Method for the detection of stress biomarkers including cortisol by fluorescence polarization |
| 05/18/2006 | US20060105396 Novel epithelial tissue imaging agent |
| 05/18/2006 | US20060105395 Methods and systems for positioning microspheres for imaging |
| 05/18/2006 | US20060105394 Methods and compositions for treatment and prevention of major depressive disorder |
| 05/18/2006 | US20060105393 Ligand-receptor tracking assays |
| 05/18/2006 | US20060105392 Differential diagnosis of vitamin B12, vitamin B6, and folic acid disorders |
| 05/18/2006 | US20060105391 Device and method for separating molecules |
| 05/18/2006 | US20060105390 Method of characterizing heterogeneity in receptor-ligand interactions and related method of assay signal histogram transformation |
| 05/18/2006 | US20060105388 Incorporation of hapten groups during the production of carriers for the determination of analytes |
| 05/18/2006 | US20060105386 17867, a novel human aminopeptidase |
| 05/18/2006 | US20060105384 Detection of DNA damage |
| 05/18/2006 | US20060105383 Biopolymer detecting method and biochip |
| 05/18/2006 | US20060105382 Microfluidic channels with attached biomolecules |
| 05/18/2006 | US20060105381 Polymorphisms of the OCTN1 cation transporters associated with inflammatory bowel disorders |
| 05/18/2006 | US20060105380 Synthesizing cDNA via primers, mixing with second sample, transcribing, then detecting |
| 05/18/2006 | US20060105378 Tenascin-C nucleic acid ligands |
| 05/18/2006 | US20060105377 Screening to optimize RNAi |
| 05/18/2006 | US20060105376 Novel full-length cDNA |
| 05/18/2006 | US20060105371 Using surface-mediated protein transfected cell microarrays to screen polypeptide and enzyme activities; high throughput assay; drug screening |
| 05/18/2006 | US20060105367 Method and markers for the diagnosis of Graft versus Host Disease (GvHD) |
| 05/18/2006 | US20060105353 Non-invasive prenatal fetal cell diagnostic method |
| 05/18/2006 | US20060105352 Method for sensitive detection of multiple biological analytes |
| 05/18/2006 | US20060105350 Method and system for sorting and separating particles |
| 05/18/2006 | US20060105349 Device and method for purification of biological materials |
| 05/18/2006 | US20060105346 Human prostaglandin FP receptor variants and methods of using same |
| 05/18/2006 | US20060105345 Method for diagnosing lung transplantation rejection |
| 05/18/2006 | US20060105344 Modulation of deubiquitinase family members |
| 05/18/2006 | US20060105343 Methods for diagnosis and prognosis of cancer |
| 05/18/2006 | US20060105338 Method and apparatus for correcting position and attitude of object to be held |
| 05/18/2006 | US20060105337 Solid phase based nucleic acid assays combining high affinity and high specificity |
| 05/18/2006 | US20060105336 autologous T cell vaccines; multiple sclerosis |
| 05/18/2006 | US20060105335 Color coated layer-by-layer microcapsules serving as combinatory analysis libraries and as specific optical sensors |
| 05/18/2006 | US20060105333 Method for diagnosis of intestinal-type gastric tumors |
| 05/18/2006 | US20060105332 Treatment of tissue specimens |
| 05/18/2006 | US20060105330 Diagnostics and remedies for malignant brain tumor |
| 05/18/2006 | US20060105329 Gene panel participating in liver regeneration |
| 05/18/2006 | US20060105328 high speed detection od viruses using monoclonal antibodies; applying sample to porous membrane; using solution of lactic and citric acid,detergent and mucolytic agent; binding to antigen |
| 05/18/2006 | US20060105327 Inhibition of the SRC kinase family pathway as a method of treating HBV infection and hepatocellular carcinoma |
| 05/18/2006 | US20060105326 Method for isolating proteins or protein and nucleic acid associations, or particle and protein complexes, reagent and uses |
| 05/18/2006 | US20060105323 Multi-reporter gene model for toxicological screening |
| 05/18/2006 | US20060105319 Method for converting venous blood values to arterial blood values, system for utilising said method and devices for such system |
| 05/18/2006 | US20060105078 Method of screening malt and process for producing foaming malt beverage |
| 05/18/2006 | US20060105043 Porous nanostructures and methods involving the same |
| 05/18/2006 | US20060104990 Mixture comprising group B streptococcal peptide for use in generating vaccine and immunoglobulins for diagnosis, prevention and treatment of urinary tract infections |
| 05/18/2006 | US20060104987 Rhesus D antigen encoded by a nucleic acid molecule carrying one or more specific missense mutations used for determining whether a patient that is in need of a blood transfusion needs to be transfused with RhD negative blood |